Diversified Chemicals

Penford Corporation (NASDAQ: PENX) is dropping sharply, down almost 10% on heavy volume. Penford is a thinly traded name, trading only 37,000 shares per day, so for it to be down sharply this morning on almost its entire average daily volume 40 minutes into trading is something to note. The...

PPG Industries (NYSE: PPG) today announced the appointment of Anup Jain as vice president, strategic planning and corporate development, effective Jan. 1, 2011.

Jefferies is out with a research report this morning, where it reiterates its Buy rating on Ashland (NYSE: ASH); it has a $68.00 price target on the stock. The Jefferies analysts said that, while near-term margin pressures in Valvoline are balancing recoveries in other segments, they are...

FMC Corporation (NYSE: FMC) announced it will be paying a quarterly dividend of 12.5 cents per share, payable on Jan. 20, 2011, to shareholders of record on Dec. 31, 2010. At last check, shares were off 24 cents to $79.78.

FMC Corporation (NYSE: FMC) announced today that its Board of Directors declared a regular quarterly dividend of 12.5 cents per share, payable on January 20, 2011, to shareholders of record at the close of business on December 31, 2010.

Apogee Enterprises Inc. (APOG) reported third-quarter fiscal 2011 operating loss of 8 cents per share compared with operating earnings of 39 cents in the year-ago quarter. The operating loss per share in the reported quarter was an improvement over the Zacks Consensus Estimate of a loss of 10...

Apogee Enterprises Inc. (APOG) reported third-quarter fiscal 2011 operating loss of 8 cents per share compared with operating earnings of 39 cents in the year-ago quarter. The operating loss per share in the reported quarter was an improvement over the Zacks Consensus Estimate of a loss of 10...

The Dow Chemical Company (NYSE: DOW) announced today that it plans to build a propylene glycol plant in Map Ta Phut, Thailand, with a production capacity of up to 150 KTA. The new PG facility will utilize propylene oxide derived from the new, sustainable hydrogen peroxide to propylene oxide...

Below are the top specialty chemical stocks on the NYSE and the NASDAQ in terms of operating margin. The trailing-twelve-month operating margin at Gulf Resources Inc (NASDAQ: GFRE) is 41.83%. GFRE's PEG ratio is 0.38. The trailing-twelve-month operating margin at ShengdaTech Inc (NASDAQ: SDTH) is...

Here's a list of events and conferences of interest for tomorrow, December 15. Celgene (NASDAQ: CELG), Dendreon (NASDAQ: DNDN) and ViroPharma Incorporated (NASDAQ: VPHM) are all scheduled to speak at the Deutsche Bank Securities Inc. BioFEST Conference. Eastman Chemical Company (NYSE: EMN) and...

DuPont (NYSE: DD) Chair and CEO Ellen Kullman told investors at the Bank of America Merrill Lynch Global Industries Conference that DuPont's market-driven science and disciplined execution will help grow revenues to $33-34 billion in 2011 from about $31 billion this year. The company also has set...

Oil and gas production company Occidental Petroleum Corporation (OXY) sold $2.6 billion notes in three tranches. The issue was rated A2 by Moody's Investors Service and A by Standard & Poor's. One offering comprised $600 million of 1.45% senior notes due December 13, 2013, at an offer price...

Oil and gas production company Occidental Petroleum Corporation (OXY) sold $2.6 billion notes in three tranches. The issue was rated A2 by Moody's Investors Service and A by Standard & Poor's. One offering comprised $600 million of 1.45% senior notes due December 13, 2013, at an offer price...

Recently, biopharmaceutical company, Micromet Inc. (MITI) presented updated durability data from a phase II study of its blood cancer pipeline drug blinatumomab (MT103) at the annual meeting of the American Society of Hematology (ASH). The phase II study was evaluating the safety and efficacy...

Recently, biopharmaceutical company, Micromet Inc. (MITI) presented updated durability data from a phase II study of its blood cancer pipeline drug blinatumomab (MT103) at the annual meeting of the American Society of Hematology (ASH). The phase II study was evaluating the safety and efficacy...